Welcome to The Weekly Skin Scan where our editors will keep you up-to-date on the latest news and research that could impact your practice. Browse more stories here.
 
Acne and Rosacea
 
Tazarotene lotion shows positive phase 3 results.
Topical may help patients suffering from moderate-to-severe acne vulgaris.
 
ADVERTISEMENT
 
Room for improvement in rosacea classification system
William James, M.D. believes refinements should be made in some of the definitions of the clinical characteristics of rosacea. Read his thoughts in this article.
 
ADVERTISEMENT
 
Psoriasis and Atopic Dermatitis
 
How to reach optimal QOL for pediatric patients
Researchers recently studied the relationship between disease severity improvement, treatment type and quality of life in pediatric patients with plaque psoriasis. Here’s what they discovered.
 
A long-term option for AD
Recent findings suggest that dupilumab could be a safe, long-term treatment option for patients with moderate-to-severe atopic dermatitis.
 
Skin Cancer
 
Systemic option for squamous cell carcinoma
A new systemic medication option offers promising results for patients with high-risk squamous cell carcinoma for whom surgery has not worked, says this expert.

Connect with us on Twitter and Facebook for daily updates.
ADVERTISEMENT
 
From our Latest Issue
 
Dermatology Times cover
A quick guide to the January issue
 
Did I wrongfully terminate my employee?
 
Nonthermal energy shows promise for back acne